Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Xie

Showing results (411-420 of 487) with videos related to

Pageof 49
Sort By:
Physical Review Letters|March 28, 2015
Detection of a superconducting phase in a two-atom layer of hexagonal Ga film grown on semiconducting GaN(0001)Hui-Min Zhang, Yi Sun, Wei Li, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
European Cells & Materials|October 18, 2021
Bone infection: a clinical priority for clinicians, scientists and educatorsT F Moriarty, G Muthukrishnan, J L Daiss, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Potent reaction hijacking inhibitors of <i>Plasmodium falciparum</i> asparagine tRNA synthetaseXi Ye, Lisl Y Esherick, Nutpakal Ketprasit, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasomeStanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Research Square|August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetaseStanley C Xie, Yinuo Wang, Craig J Morton, et al.
Pageof 49

Showing results (411-420 of 487) with videos related to

Sort By:
Pageof 49
Physical Review Letters|March 28, 2015
Detection of a superconducting phase in a two-atom layer of hexagonal Ga film grown on semiconducting GaN(0001)Hui-Min Zhang, Yi Sun, Wei Li, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
European Cells & Materials|October 18, 2021
Bone infection: a clinical priority for clinicians, scientists and educatorsT F Moriarty, G Muthukrishnan, J L Daiss, et al.
Oncogene|December 6, 2011
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancerW Liu, J Lindberg, G Sui, et al.
Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Potent reaction hijacking inhibitors of <i>Plasmodium falciparum</i> asparagine tRNA synthetaseXi Ye, Lisl Y Esherick, Nutpakal Ketprasit, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2021
Design of proteasome inhibitors with oral efficacy in vivo against <i>Plasmodium falciparum</i> and selectivity over the human proteasomeStanley C Xie, Riley D Metcalfe, Hirotake Mizutani, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Research Square|August 7, 2023
Reaction hijacking inhibition of <i>Plasmodium falciparum</i> asparagine tRNA synthetaseStanley C Xie, Yinuo Wang, Craig J Morton, et al.
Pageof 49